China’s Phoenix Healthcare Buying Hong Kong UMP; IVF Kits Distribution In China Signed
Roguero Caler | | Jul 14, 2015 07:45 PM EDT |
(Photo : Getty Images/ChinaFotoPress ) China's healthcare sector is advancing.
The healthcare sector of China is on the move. The first ever mainland hospital firm in Hong Kong, Phoenix Health Group, has already confirmed that it is purchasing 20 percent of UMP Healthcare Holdings.
The deal between the two is valued at HK$180 million and it is set to be finalized this Thursday, with True Point still holding on to the 80 percent of the UMP Healthcare Holdings, according to South China Morning Post.
Like Us on Facebook
The agreement is expected to generate positive response since UMP has been delivering quality services in Shanghai, Macau and Beijing, apart from Hong Kong.
Additionally, Phoenix and UMP are also bound by a 50-50 deal that aims to establish the healthcare system - outpatient clinics, medicine business and others - in the Beijing-Tianjin-Hebel region.
This joint venture will commence with the partnering companies building three clinics in Beijing. In the long rung, Phoenix and UMP are planning to build 10 or more clinics in China's capital city.
Meanwhile, another advancement in China's healthcare sector is the signing of the agreement between Medicare International Trading Limited and Reproductive Health Science (RHS), as per Proactive Investors.
The agreement is primarily focused on the distribution of EmbryoCollect in-vitro fertilization (IVF) kits in China, Macau and Hong Kong.
It was found that Chinese clinics conduct up to 300,000 IVF procedures annually and the demand for the procedure is expected to spike in the coming years.
In China, about 300 clinics conduct in-vitro fertilization. In Hong Kong, 13 clinics perform approximately 5,000 IVF cycles in a year, while there are only three Macau clinics that conduct nearly 400 cycles each year.
The agreement comes amid RHS's desire to establish a strong network of distributors worldwide for the IVF market sales to skyrocket.
Interestingly, the agreement also comes amid China's highly criticized one-child policy due to its ballooning population, Odisha News Insight reports.
The policy is said to have helped diminish the country's population by 400 million, making China step down from its thrown of being the world's most populated nation.
The title now belongs to India, which according to a census has already surpassed the one-billion mark by having 1,210,193,422 people. The census was carried out in 2011, so it's not surprising if the figure has increased by millions as of 2015.
Tagshealthcare, Hong Kong, IVF, hospitals
©2015 Chinatopix All rights reserved. Do not reproduce without permission
EDITOR'S PICKS
-
Did the Trump administration just announce plans for a trade war with ‘hostile’ China and Russia?
-
US Senate passes Taiwan travel bill slammed by China
-
As Yan Sihong’s family grieves, here are other Chinese students who went missing abroad. Some have never been found
-
Beijing blasts Western critics who ‘smear China’ with the term sharp power
-
China Envoy Seeks to Defuse Tensions With U.S. as a Trade War Brews
-
Singapore's Deputy PM Provides Bitcoin Vote of Confidence Amid China's Blanket Bans
-
China warns investors over risks in overseas virtual currency trading
-
Chinese government most trustworthy: survey
-
Kashima Antlers On Course For Back-To-Back Titles
MOST POPULAR
LATEST NEWS
Zhou Yongkang: China's Former Security Chief Sentenced to Life in Prison
China's former Chief of the Ministry of Public Security, Zhou Yongkang, has been given a life sentence after he was found guilty of abusing his office, bribery and deliberately ... Full Article
TRENDING STORY
-
China Pork Prices Expected to Stabilize As The Supplies Recover
-
Elephone P9000 Smartphone is now on Sale on Amazon India
-
There's a Big Chance Cliffhangers Won't Still Be Resolved When Grey's Anatomy Season 13 Returns
-
Supreme Court Ruled on Samsung vs Apple Dispute for Patent Infringement
-
Microsoft Surface Pro 5 Rumors and Release Date: What is the Latest?